TORONTO, Nov. 29, 2018 /PRNewswire/ – SOL Global Investments Corp. (“SOL” or the “Company”) (CSE: SOL) (OTCQB: SOLCF) (Frankfurt:9SB) today reported record financial results for the six-months ended on September 30, 2018.

SpinalCyte received FDA Investigational New Drug clearance for CybroCell, its fibroblast-based therapy to treat degenerative disc disease.

CEDAR RAPIDS, Iowa (KCRG)- Nurses, doctors and even health care students who want to practice on pediatric patients in Cedar Rapids can now turn to a new high-tech helper at Mercy Medical Center. It’s a patient simulator that goes by the name “Pediatric HAL.”